Cannabix and AlcoPro: A Breath of Fresh Opportunity in Marijuana Breath Testing

In the rapidly evolving cannabis industry, one company is making waves with its innovative marijuana breath testing technology. Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) has entered into a memorandum of understanding (MOU) with AlcoPro Inc. to collaborate on marketing efforts for the Cannabix Marijuana Breathalyzer (CMB) in the United States. This strategic partnership presents an attractive investment opportunity for those interested in undervalued sectors like energy, as it taps into the growing demand for marijuana breath testing devices.

As marijuana legalization expands across the United States, so does the need for accurate and reliable testing methods to detect cannabis-impaired driving and workplace safety. Cannabix's marijuana breathalyzer technology is focused on "recent use" detection of delta-9 THC, setting it apart from widely used urine, blood, and saliva methods that can detect delta-9 THC many hours, days, or even weeks after consumption. This unique approach caters to the growing demand for marijuana breath testing devices, with a 2019 survey by the AAA Foundation for Traffic Safety estimating that 14.8 million drivers in the U.S. reported getting behind the wheel within one hour after using marijuana (1).

AlcoPro, a well-established distributor of drug and alcohol testing instruments, will include the CMB hardware in its upcoming 2025 product catalogue, mailed to over 70,000 businesses globally. This exposure will provide Cannabix with preliminary marketing exposure to AlcoPro customers, gauge interest, and work towards a future distribution agreement. This partnership signals AlcoPro's confidence in Cannabix's technology and enhances the company's credibility in the market.



Cannabix has made significant updates to its CMB technology to meet suggested emerging regulatory requirements in preparation for marketing. These updates include a smaller, lightweight, more ergonomic design for the Breath Collection Unit (BCU), a new removable, long-lasting, rechargeable Li-ion battery, and a modified sample collection cartridge that can collect a single sample or dual sample, consistent with federally regulated programs. These advancements demonstrate Cannabix's commitment to innovation and its ability to adapt to market needs.

The marijuana breath testing devices sector, as represented by Cannabix Technologies Inc., offers an attractive investment opportunity due to its growing demand, strong market potential, strategic partnerships, technological advancements, and position as an under-owned sector. Investors interested in undervalued sectors like energy may find this opportunity appealing, as the growing demand for cannabis breath testing devices, coupled with Cannabix's innovative technology and strategic partnerships, positions the company well for potential growth and value creation.

In conclusion, the partnership between Cannabix and AlcoPro presents an attractive investment opportunity in the under-owned sector of marijuana breath testing devices. With its innovative technology, strategic partnerships, and growing demand, Cannabix is well-positioned for potential growth and value creation. As an investor, it's essential to stay informed about emerging trends and opportunities in the cannabis industry, and Cannabix's marijuana breath testing technology is a compelling addition to your watchlist.

References:
(1) https://www.nytimes.com/2025/01/01/us/marijuana-driving-impairment.html